Alexei Gogolev
Stock Analyst at JP Morgan
(3.53)
# 866
Out of 5,241 analysts
108
Total ratings
52.5%
Success rate
4.94%
Average return
Main Sectors:
Stocks Rated by Alexei Gogolev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $33 → $28 | $18.97 | +47.60% | 4 | May 14, 2026 | |
| WIX Wix.com | Maintains: Underweight | $91 → $86 | $54.67 | +57.31% | 7 | May 13, 2026 | |
| INTA Intapp | Maintains: Overweight | $58 → $47 | $20.99 | +123.92% | 5 | May 6, 2026 | |
| GDDY GoDaddy | Maintains: Overweight | $167 → $154 | $87.18 | +76.65% | 8 | May 1, 2026 | |
| WAY Waystar Holding | Maintains: Overweight | $40 → $38 | $17.93 | +111.94% | 1 | Apr 30, 2026 | |
| CSGP CoStar Group | Maintains: Overweight | $82 → $70 | $32.68 | +114.20% | 7 | Apr 29, 2026 | |
| VRSN VeriSign | Maintains: Neutral | $273 → $278 | $297.57 | -6.58% | 3 | Apr 24, 2026 | |
| PHR Phreesia | Downgrades: Neutral | $24 → $16 | $8.77 | +82.44% | 3 | Mar 31, 2026 | |
| BRZE Braze | Maintains: Overweight | $32 → $33 | $20.87 | +58.12% | 2 | Mar 25, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $129 → $123 | $82.17 | +49.69% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $296 | $158.86 | +86.33% | 2 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $205 → $162 | $141.91 | +14.16% | 2 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $300 | $151.70 | +97.76% | 5 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $46 → $48 | $29.56 | +62.38% | 5 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $74 | $33.71 | +119.52% | 1 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $26 | $24.35 | +6.78% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $56 → $51 | $32.07 | +59.03% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $86 → $94 | $64.58 | +45.56% | 3 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $271 → $288 | $130.14 | +121.30% | 9 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $85 | $46.33 | +83.47% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $45 | $16.61 | +170.92% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $10 → $11 | $9.51 | +15.67% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $526 | $311.89 | +68.65% | 3 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $36 → $32 | $5.19 | +516.57% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $7.62 | +267.45% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $247 → $249 | $93.02 | +167.68% | 4 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $73 → $55 | $54.17 | +1.54% | 4 | Mar 11, 2020 |
Doximity
May 14, 2026
Maintains: Neutral
Price Target: $33 → $28
Current: $18.97
Upside: +47.60%
Wix.com
May 13, 2026
Maintains: Underweight
Price Target: $91 → $86
Current: $54.67
Upside: +57.31%
Intapp
May 6, 2026
Maintains: Overweight
Price Target: $58 → $47
Current: $20.99
Upside: +123.92%
GoDaddy
May 1, 2026
Maintains: Overweight
Price Target: $167 → $154
Current: $87.18
Upside: +76.65%
Waystar Holding
Apr 30, 2026
Maintains: Overweight
Price Target: $40 → $38
Current: $17.93
Upside: +111.94%
CoStar Group
Apr 29, 2026
Maintains: Overweight
Price Target: $82 → $70
Current: $32.68
Upside: +114.20%
VeriSign
Apr 24, 2026
Maintains: Neutral
Price Target: $273 → $278
Current: $297.57
Upside: -6.58%
Phreesia
Mar 31, 2026
Downgrades: Neutral
Price Target: $24 → $16
Current: $8.77
Upside: +82.44%
Braze
Mar 25, 2026
Maintains: Overweight
Price Target: $32 → $33
Current: $20.87
Upside: +58.12%
HealthEquity
Mar 18, 2026
Maintains: Overweight
Price Target: $129 → $123
Current: $82.17
Upside: +49.69%
Feb 20, 2026
Maintains: Overweight
Price Target: $330 → $296
Current: $158.86
Upside: +86.33%
Feb 2, 2026
Downgrades: Underweight
Price Target: $205 → $162
Current: $141.91
Upside: +14.16%
Jan 30, 2026
Maintains: Overweight
Price Target: $330 → $300
Current: $151.70
Upside: +97.76%
Dec 5, 2025
Maintains: Neutral
Price Target: $46 → $48
Current: $29.56
Upside: +62.38%
Dec 5, 2025
Maintains: Overweight
Price Target: $65 → $74
Current: $33.71
Upside: +119.52%
Nov 6, 2025
Maintains: Overweight
Price Target: $28 → $26
Current: $24.35
Upside: +6.78%
Nov 6, 2025
Maintains: Neutral
Price Target: $56 → $51
Current: $32.07
Upside: +59.03%
Jul 24, 2025
Maintains: Neutral
Price Target: $86 → $94
Current: $64.58
Upside: +45.56%
Jun 25, 2025
Maintains: Overweight
Price Target: $271 → $288
Current: $130.14
Upside: +121.30%
Apr 9, 2025
Maintains: Overweight
Price Target: $97 → $85
Current: $46.33
Upside: +83.47%
Dec 9, 2024
Maintains: Overweight
Price Target: $42 → $45
Current: $16.61
Upside: +170.92%
Aug 7, 2024
Maintains: Underweight
Price Target: $10 → $11
Current: $9.51
Upside: +15.67%
Feb 15, 2024
Maintains: Overweight
Price Target: $500 → $526
Current: $311.89
Upside: +68.65%
Aug 9, 2023
Maintains: Underweight
Price Target: $36 → $32
Current: $5.19
Upside: +516.57%
Jul 31, 2023
Maintains: Outperform
Price Target: $27 → $28
Current: $7.62
Upside: +267.45%
Mar 11, 2020
Maintains: Overweight
Price Target: $247 → $249
Current: $93.02
Upside: +167.68%
Mar 11, 2020
Upgrades: Neutral
Price Target: $73 → $55
Current: $54.17
Upside: +1.54%